Proliance Retina (formally known as Vitreoretinal Associates of Washington) — Bellevue, Washington

Proliance Retina (formally known as Vitreoretinal Associates of Washington) is a clinical research site located in Bellevue, Washington, United States 98004.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Proliance Retina (formally known as Vitreoretinal Associates of Washington) has participated in 1 clinical trials.

Therapeutic areas: Dry Age-related Macular Degeneration, Macular Degeneration, Retinal Disease.

Sponsors: Gyroscope Therapeutics Limited.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Proliance Retina (formally known as Vitreoretinal Associates of Washington)?

Proliance Retina (formally known as Vitreoretinal Associates of Washington) has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Proliance Retina (formally known as Vitreoretinal Associates of Washington) conducted?

Proliance Retina (formally known as Vitreoretinal Associates of Washington) has 1 clinical trials on record. Their work covers Dry Age-related Macular Degeneration, Macular Degeneration, Retinal Disease.

Is Proliance Retina (formally known as Vitreoretinal Associates of Washington) accredited by Crixeo Health?

Proliance Retina (formally known as Vitreoretinal Associates of Washington) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Proliance Retina (formally known as Vitreoretinal Associates of Washington)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.